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Abstract
Purpose:  Postoperative  pain  and  nausea/vomitting  (PNV)  are  common  in  laparoscopic  chole-
cystectomy  patients.  Sympatholytic  agents  might  decrease  requirements  for  intravenous  or
inhalation anesthetics  and  opioids.  In  this  study  we  aimed  to  analyze  effects  of  esmolol  on
intraoperative  anesthetic-postoperative  analgesic  requirements,  postoperative  pain  and  PNV.
Methods: Sixty  patients  have  been  included.  Propofol,  remifentanil  and  vecuronium  were  used
for induction.  Study  groups  were  as  follows;  I  --  Esmolol  infusion  was  added  to  maintenance
anesthetics  (propofol  and  remifentanil),  II  --  Only  propofol  and  remifentanil  was  used  during
maintenance,  III  -- Esmolol  infusion  was  added  to  maintenance  anesthetics  (desﬂurane  and
remifentanil),  IV  --  Only  desﬂurane  and  remifentanil  was  used  during  maintenance.  They  have
been followed  up  for  24  h  for  PNV  and  analgesic  requirements.  Visual  analog  scale  (VAS)  scores
for pain  was  also  been  evaluated.
Results:  VAS  scores  were  signiﬁcantly  lowest  in  group  I  (p  =  0.001--0.028).  PNV  incidence  was
signiﬁcantly  lowest  in  group  I  (p  =  0.026).  PNV  incidence  was  also  lower  in  group  III  compared  to
group IV  (p  =  0.032).  Analgesic  requirements  were  signiﬁcantly  lower  in  group  I  and  was  lower
in group  III  compared  to  group  IV  (p  =  0.005).  Heart  rates  were  signiﬁcantly  lower  in  esmolol
groups (group  I  and  III)  compared  to  their  controls  (p  =  0.001)  however  blood  pressures  were
similar in  all  groups  (p  =  0.594).  Comparison  of  esmolol  groups  with  controls  revealed  that  there
is a  signiﬁcant  decrease  in  anesthetic  and  opioid  requirements  (p  =  0.024--0.03).
Conclusion:  Using  esmolol  during  anesthetic  maintenance  signiﬁcantly  decreases  anesthetic-
analgesic requirements,  postoperative  pain  and  PNV.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  All  rights
reserved.
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PALAVRAS-CHAVE
Esmolol;
Dor  no
pós-operatório;
Vômito  no
pós-operatório
Efeito  da  infusão  de  esmolol  sobre  a  necessidade  de  anestesia  no  intraoperatório  e
analgesia,  náusea  e  vômito  no  pós-operatório  em  um  grupo  de  pacientes  submetidos
à  colecistectomia  laparoscópica
Resumo
Objetivo:  A  dor  e  a  incidência  de  náusea  e  vômito  no  período  pós-operatório  (NVP)  são  comuns
em pacientes  submetidos  à  colecistectomia  laparoscópica.  Os  agentes  simpatolíticos  podem
diminuir a  necessidade  de  opiáceos  ou  anestésicos  inalatórios  ou  intravenosos.  Neste  estudo,
nosso objetivo  foi  analisar  os  efeitos  de  esmolol  sobre  a  necessidade  de  anestésico  no  período
intraoperatório  e  de  analgésico  no  pós-operatório  e  a  incidência  de  dor  e  NVP.
Métodos:  Sessenta  pacientes  foram  incluídos.  Propofol,  remifentanil  e  vecurônio  foram  usados
para a  induc¸ão.  Os  grupos  de  estudo  foram  os  seguintes:  grupo  I,  a  infusão  de  esmolol  foi
adicionada  aos  anestésicos  (propofol  e  remifentanil)  para  manutenc¸ão;  grupo  II,  apenas  propofol
e remifentanil  foram  usados  durante  a  manutenc¸ão;  grupo  III,  a  infusão  de  esmolol  foi  adicionada
aos anestésicos  (desﬂurano  e  remifentanil)  para  manutenc¸ão;  grupo  IV,  apenas  desﬂurano  e
remifentanil  foram  usados  durante  a  manutenc¸ão.  O  período  de  acompanhamento  foi  de  24
horas para  avaliar  a  incidência  de  NVP  e  a  necessidade  de  analgésicos.  Os  escores  de  dor  também
foram avaliados  por  meio  da  Escala  Visual  Analógica  (EVA).
Resultados:  Os  escores  EVA  foram  signiﬁcativamente  menores  no  grupo  I  (p  =  0,001--0,028).  A
Incidência de  NVP  foi  signiﬁcativamente  menor  no  grupo  I  (p  =  0,026).  NVP  também  foi  menor
no grupo  III  em  relac¸ão  ao  grupo  IV  (p  =  0,032).  A  necessidade  de  analgésicos  foi  signiﬁcativa-
mente menor  no  grupo  I  e  menor  no  grupo  III  em  relac¸ão  ao  grupo  IV  (p  =  0,005).  A  frequência
cardíaca foi  signiﬁcativamente  menor  nos  grupos  esmolol  (grupos  I  e  III)  comparados  aos  con-
troles (p  =  0,001),  mas  a  pressão  arterial  foi  semelhante  em  todos  os  grupos  (p  =  0,594).  A
comparac¸ão entre  os  grupos  esmolol  e  controles  revelou  que  houve  uma  diminuic¸ão.
Conclusão:  O  uso  de  esmolol  durante  a  manutenc¸ão  da  anestesia  reduz  signiﬁcativamente  a
necessidade  de  anestésico-analgésico,  dor  e  incidência  de  NVP.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os
direitos reservados.
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aparoscopic  cholecystectomy  became  a  daily  routine
rocedure  with  low  cost  and  high  patient  satisfaction
y  developments  in  surgical  and  anesthetic  techniques.
espite  of  high  success  rates  in  postoperative  pain  and
ausea-vomitting  (PNV)  are  still  important  problems  that
elay  patient  discharge.  Intra  and  postoperative  hemo-
ynamic  stability  and  efﬁcient  analgesia  might  prevent
hese  complications.  In  these  patients  hemodynamic  stress
esponses  like  hypertension  and  tachycardia  might  develop
s  a  reﬂex  to  endotracheal  intubation  or  surgical  inter-
ention  itself.  Insufﬂation  of  carbondioxide  into  peritoneal
avity  might  also  trigger  this  response.  Plasma  concen-
rations  of  stress  hormones  might  also  increase  secondary
o  side  effects  of  some  anesthetic  agents.  Hemodynamic
nstability  is  an  important  triggering  factor  for  PNV.1 Dif-
erent  techniques  or  anesthetic  agents  could  be  used  to
ecrease  hemodynamic  response  and  related  postoperative
omplications.2--4 Increasing  volatile  anesthetic  concentra-
ions  and/or  opioid  usage  are  some  methods  that  could
e  preferred.2 However  intraoperative  opioids  might  also
elay  postoperative  recovery  and  increase  PNV  rates.  Sym-
atholytic  agents  decrease  hemodynamic  response  and  so
equirement  for  opioids.  These  agents  are  alternatives
or  opioids  and  also  might  decrease  requirements  for
a
t
i
untravenous  or  inhalation  anesthetics.2--8 In  this  study  we
imed  to  analyze  effects  of  esmolol,  a cardioselective  beta-
 (1) adrenergic  receptor  antagonist,  on  intraoperative
nesthetic--postoperative  analgesic  requirements,  postop-
rative  pain  and  PNV.
ethodology
tudy  was  designed  as  a  prospective  study  after  approval
rom  local  ethical  committee  (KA174-09012013).  60  patients
ged  between  18  and  60  years  who  underwent  laparoscopic
holecystectomy  have  been  included.  Exclusion  criterias
ere  as  follows;  previously  known  cardiovascular  disease,
evere  hemodynamical  instability  during  operation  [mean
lood  pressure  (MBP)  <70  mmHg],  chronic  opioid  usage,
sthma,  being  obese  or  underweighted  (body  mass  index
30  or  <18.5),  diabetes  mellitus,  using    blockers  or  cal-
ium  channel  blockers.  No  premedications  were  used  before
peration.  Electrocardiographic  (ECG),  invasive  intraarte-
ial  blood  pressures,  MBP,  peripheral  oxygen  saturations
SpO2)  vs.  bispectral  index  (BIS)  monitorizations  were  done
nd  recorded  as  study  data.  Propofol  2.5  mg/kg,  remifen-
anil  1  g/kg  and  vecuronium  0.1  mg/kg  were  used  for
nduction  in  all  patients.  50%  O2 and  fresh  air  mixture  was
sed  during  mechanical  ventilation.  End-tidal  CO2 (ETCO2)
n,  na
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bIntraoperative  esmolol  infusion  decreases  postoperative  pai
levels  were  aimed  to  be  between  35  and  45  mmHg  and  fresh
gas  ﬂow  rate  was  3  L/min  in  all  patients.
Study  groups  were  as  follows:
Group  I:  After  induction,  5  min  esmolol  infusion  (total
dose  1  mg/kg)  was  used.  Peroperative  esmolol  dose  was
planned  as  10  g/kg/min.  Maintenance  anesthetics  were
75--85  g/kg/min  propofol  and  0.2  g/kg/min  remifentanil.
Group  II:  Maintenance  anesthetics  were
75--85  g/kg/min  propofol  and  0.2  g/kg/min  remifentanil.
No  esmolol  infusion  was  used.
Group  III:  After  induction,  5  min  esmolol  infusion  (total
dose  1  mg/kg)  was  used.  Peroperative  esmolol  dose  was
planned  as  10  g/kg/min.  Maintenance  anesthetics  were
4--8%  desﬂurane  and  0.2  /kg/min  remifentanil.
Group  IV:  Maintenance  anesthetics  were  4--8%  desﬂu-
ran  and  0.2  /kg/min  remifentanil.  No  esmolol  infusion  was
used.
Group  II  was  designed  as  control  for  group  I  and  group
IV  was  designed  as  control  for  group  III.  Adjustments  in
esmolol  and  other  anesthetic  drug  dosages  were  done
according  to  MBP  and  heart  rates  of  all  individual  patient
as  follows.  Propofol  and  desﬂurane  concentrations  were
changed  continuously  during  operation  by  aiming  BIS  val-
ues  between  40-60.  Intravenous  atropine  and  ephedrine
were  planned  to  be  used  in  case  of  any  intraoperative
bradycardia  (40  pulse/min)  or  hypotension  (MBP  <70  mmHg).
In  case  of  a  decrease  in  heart  rates  and  MBP  near  to
above  mentioned  critical  levels  we  ﬁrst  decreased  remifen-
tanil  infusion  rates  and  then  decreased  esmolol  infusion
rates.  Total  requirements  of  propofol,  remifentanil,  esmolol
and  desﬂuran  were  calculated  and  recorded  for  each
patient.
All  patients  were  followed  up  in  postoperative  critical
care  (PACU)  unit  for  at  least  30  min  after  surgery.  Postopera-
tive  ECG,  MBP,  heart  rates,  peripheral  SpO2 monitorizations
were  done  and  recorded  as  study  data.  0.5  mg/kg  tramadol
was  given  to  patients  with  >3  points  in  visual  analog  scale
(VAS)  evaluations.  10  mg  metoclopramide  IV  was  applied  to
al  patients  in  PACU.  All  patients  were  discharged  from  PACU
to  standart  care  clinics  after  they  had  an  Aldrete  score  >9
and  they  have  been  followed  up  for  another  24  h  for  PNV
and  analgesic  requirements.  VAS  was  also  been  reevaluated
at  12th  and  24th  hours  and  scores  were  recorded  as  study
data.
Statistical methodology
Statistical  Package  for  Social  Sciences  (SPSS  for  Windows,
Chicago,  IL,  USA)  version  of  14.0  was  used  for  data  anal-
ysis.  Data  were  submitted  to  a  frequency  distribution
analysis  by  Kolmogorov--Smirnov’s  test.  Values  displaying
normal  distribution  were  expressed  as  the  mean  ±  SD  and
values  with  skew  distribution  were  expressed  as  median
(interquartile  range).  Differences  between  numeric  varia-
bles  were  tested  with  one-way  ANOVA  or  Kruskal--Wallis
tests  where  appropriate.  Tukey  test  was  used  for  post  hoc
analyses.  Categorical  data  were  compared  by  chi-square
or  Fisher’s  tests.  The  value  of  conﬁdence  interval  was
accepted  as  95%  and  statistical  signiﬁcance  was  accepted  as:
p  <  0.05.
t
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esults
0  laparoscopic  cholecystectomy  patients  (45  female,  age;
7.8  ±  12.1  years)  were  included.  Study  groups  were  sta-
istically  similar  in  means  of  demographic  (age  and  gender
istribution)  chatracteristics  (Table  1).  Surgery  and  anesthe-
ia  durations  were  also  similar  however  there  was  a  tendency
or  increased  surgery  (p:  0.054)  and  anesthesia  durations
p  =  0.097)  in  group  I  and  group  II  compered  to  groups  III
nd  IV  (Table  1).  These  durations  were  similar  when  esmolol
roups  were  compared  with  only  their  controls  (group  I  vs.  II
nd  group  III  vs.  IV).  Mean  BIS  values  were  similar  between
roups  and  were  between  40  and  60  (p  =  0.270).  VAS  score
easured  in  PACU,  12th  and  24th  postoperative  hours  were
igniﬁcantly  lowest  in  group  I (p  =  0.001,  0.003,  0.028  respec-
ively).  PNV  incidence  in  postoperative  24  h  was  signiﬁcantly
owest  in  group  I  compared  to  all  other  groups  (p  = 0.026).
owever  PNV  incidence  was  also  lower  in  group  III  com-
ared  to  its’  control,  group  IV  (p  =  0.032).  Similarly  analgesic
equirements  in  postoperative  24  h  were  signiﬁcantly  lower
n  group  I  compared  to  all  other  groups  and  was  lower  in
roup  III  compared  to  its’  control,  group  IV  (p  =  0.005).  When
ompared  in  means  of  hemodynamical  parameters  heart
ates  were  signiﬁcantly  lower  in  esmolol  groups  (group  I and
II)  compared  to  their  controls  (p  =  0.001)  however  MBP  val-
es  were  similar  in  all  groups  (p  =  0.594).  Heart  rates  and
BP  values  in  PACU  were  similar  between  groups  (p  =  0.327,
.094  respectively).  Comparison  of  esmolol  groups  with  con-
rols  in  means  of  anesthetic  requirements  revealed  that
here  is  a signiﬁcant  decrease  in  desﬂuran,  propofol  and
emilfentanil  requirements  (p  =  0.024,  0.03,  0.026  respec-
ively).
iscussion
espite  of  high  success  rates  in  laparoscopic  cholecys-
ectomy  procedures,  postoperative  pain  and  PNV  are  still
ommon  problems.  Efﬁcient  postoperative  analgesia  and
ntraoperative  hemodynamic  stability  are  very  important
actors  that  affect  complication  rates  in  these  patients.9
NV  has  an  incidence  40--75%  and  usually  delays  patient
ischarge.9,10 Female  gender,  smoking,  previous  PNV  history,
arsickness  history,  postoperative  opioid  usage,  intraopera-
ive  hypotension  and  orthostotic  hypotension  are  major  risk
actors  for  PNV.11--13
Some  modiﬁcations  in  anesthesia  protocols  are  being
esearched  by  clinicians  to  decrease  incidence  of  these
omplications.  In  this  study  we  observed  that  decreasing
pioid  and  anesthetic  doses  and  addition  of  esmolol  into
nesthesia  protocol  decreases  PNV  rates  and  postopera-
ive  pain  comlication  rates  without  causing  any  signiﬁcant
emodynamic  complication.  Using  high  opioid  doses  in  daily
aparascopic  procedures  might  cause  a delay  in  recovery
uration,  increased  PNV  and  urinary  retention  rates.  Beta
lockers  could  be  used  effectively  as  alternative  agents  to
ecrease  opioid  requirements.  Possible  positive  effects  of
eta  blockers  are  hemodynamic  stability,  decreased  anes-
hetic  and  analgesic  requirements,  decreased  PNV  rates  and
ecreased  intubation  stress.
Effects  of  beta  blockers  in  angina  pectoris,  hypertension
nd  arrythmia  are  very  well  known.14,15 Using  propranolol
144  N.  Dereli  et  al.
Table  1  Comparison  of  study  groups.
Group  I  (n  =  12)  Goup  II  (n  =  15)  Group  III  (n  =  21)  Group  IV  (n  =  12)  p-Value
Gender  (F/M) 9/3  12/3  15/6  8/4  0.724
Gender (years)  44.3  ±  13.2  45.3  ±  14.2  51.7  ±  9.3  48.8  ±  11.9  0.318
Surgery duration  (min)  79.1  ±  23.9  82.6  ±  31.3  62.2  ±  24.1  55.5  ±  23.5  0.054
Anesthesia duration  (min)  92.1  ±  25.6  91.1  ±  35.7  77.7  ±  22.9  68.1  ±  24.8  0.097
Postoperative  VAS  (in  PACU)  0.5  (1)  3  (2)  2  (1)  3  (2)  0.001
Postoperative  VAS  (12th  hours)  0.5  (1)  2  (2)  2  (1.5)  2.5  (2)  0.003
Postoperative  VAS  (24th  hours)  0  (0)  1  (2)  1  (2)  0.5  (2.75)  0.028
Analgesia requirement  in
postoperative  24  h
2/12  (16.7%)  10/15  (66.7%)  5/21  (23.8%)  8/12  (66.7%)  0.005
PNV in  postoperative  24  h 1/12  (8.3%) 6/15  (40%) 7/21  (33.3%) 8/12  (66.7%) 0.03
Intraoperative  heart  rate
(pulse/min)
66.4  ±  9.1 77.4  ±  7.5 69.3  ±  6.4 72.8  ±  6.1 0.001
Intraoperative  mean  blood
pressure  (mmHg)
91  ±  15.7  92.1  ±  11.7  91.6  ±  8.3  86.6  ±  10.8  0.594
Heart rate  in  PACU  (pulse/min)  63.6  ±  11.9  72.9  ±  12.4  67.4  ±  12.1  65.7  ±  15.6  0.327
Mean blood  pressure  in  PACU
(mmHg)
79.7  ±  15.1  89.1  ±  16.3  80.9  ±  13  76.8  ±  9.5  0.094
Mean BIS  value  51.9  ±  20.2  51.7  ±  12.6  46.7  ±  9.4  43.4  ±  8.5  0.270
Propofol requirements  (mL)  328.4  ±  173.8  530.1  ±  244.1  --  --  0.024a
Desﬂurane  requirements  (mL)  --  --  31.2  ±  12.3  43.6  ±  18.9  0.03b
Remilfentanil  requirements  (mL) 174.6  ±  100.8  269.2  ±  105.2  132.9  ±  146.0  562.4  ±  152.4  0.026a
0.0001b
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op-Value between group 1 and 2.
b p-Value between group 3 and 4.
o  decrease  intraoperative  myocardial  ischemia  in  high  risk
atients  is  a  common  practice  for  anesthesiologists.  How-
ver  long  half  life  of  propranalol  limits  its’  usage.  Esmolol
s  an  ideal  beta  blocker  that  has  shorter  half  life  and
ardioselectivity.  Its’  effect  start  fast  and  also  gets  elim-
nated  in  a  short  time  with  a  half  life  of  9.2  ±  2  min.16 It
hows  its’  maximal  effect  on  heart  rate  and  blood  pres-
ure  in  1--2  min  after  intravenous  injection.17 Esmolol  could
e  used  by  intravenous  infusion  or  boluses  due  to  its’
harmacodynamic  and  pharmacokinetic  properties.  Esmolol
upresses  adrenergic  response  against  laryngoscopy,  tra-
heal  intubation--extubation  and  peritoneal  irritation  due  to
O2 insufﬂation  during  laparoscopy.  Using  esmolol  infusion
ntraoperatively  gives  opportunity  to  control  sympathetic
ystem  response  and  there  by  decrease  myocardial  O2
onsumption.18--21 It  was  also  reported  to  decrease  periop-
rative  nausea  response.22
In  patients  who  received  esmolol  with  standart  anes-
hesia  protocol  (groups  I  and  III)  we  observed  that
ntraoperative  heart  rates  were  signiﬁcantly  lower,  how-
ver  there  was  no  signiﬁcant  difference  in  intraoperative
BP  compared  to  control  groups.  We  also  observed  that
here  was  no  signiﬁcant  difference  between  study  groups
nd  controls  in  means  of  heart  rates  and  blood  pressure
uring  recovery  phase  in  PACU.  Depending  on  these  ﬁndings
e  think  that  by  close  hemodynamic  follow-up  and  titrating
smolol  doses,  anesthesiologist  could  avoid  unwanted  side
ffects  of  esmolol  like  hypotension,  and  also  could  use  this
ose  titration  advantage  and  decreased  intraoperative  heart
ates  to  decrease  myocardial  O2 requirements.  Supporting
ur  ﬁndings  Smith  and  colleques  compared  esmolol  and
lfentanil  in  means  of  hemodynamic  stability  in  a  group  of
f
W
a
trthroscopic  surgery  patients  and  reported  that  esmolol  as
 good  alternative  with  less  side  effects.1 Coloma  and  colle-
ues  also  compared  esmolol  with  remilfentanil  in  means  of
emodynamic  stability  in  a  group  of  laparascopic  gyneco-
ogical  surgery  patients  and  reported  it  provides  a  beter
emodynamic  stability.5
Remifentanil  is  a  synthetic  opioid  agonist.  Its’  effects
eaches  maximal  levels  in  a  relatively  short  period  of  time.
t  is  eliminated  by  tissue  and  blood  esterases  and  has  a  very
hort  half  life.23 Because  of  these  properties  remifentanil
s  a good  alternative  for  fentanyl.24 However,  in  some  stud-
es  remifentanil  was  reported  to  cause  hypotension.  Hogue
nd  colleques  reported  that  20%  of  patients  who  received
emifentanil  developed  hypotension.25 Schuttler  and  colle-
ues  and  McAtamney  and  colleques  also  reported  similar
esults  in  two  different  studies.26,27 In  our  study  we  observed
hat  addition  of  esmolol  decreases  remifentanil  require-
ents  signiﬁcantly.  Depending  on  these  ﬁndings  we  believe
hat  adding  esmolol  in  anesthesia  protocols  with  remifen-
anil  will  signiﬁcantly  decrease  hemodynamic  complications
nd  hypotension.  According  to  our  ﬁndings  addition  of
smolol  also  decreases  requirements  for  propofol  and  desﬂu-
ane.  It  could  easily  be  foreseen  that  decreased  anesthetic
equirements  will  cause  less  side  effects  and  also  a  decrease
n  economical  cost.  Supporting  our  ﬁndings  Johansen  and
olleques  reported  similar  results.  They  compared  effect  of
smolol  addition  on  propofol  and  60%  N2O  requirements  and
bserved  that  esmolol  signiﬁcantly  decreases  requirements
or  both  agents.7 In  two  different  studies  Topc¸u et  al.28 and
ilson  et  al.29 reported  esmolol  decreased  both  propofol
nd  remifentanil  requirements.  Chia  and  colleques  reported
hat  addition  of  esmolol  decreases  anesthetic  requirements
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and  also  postoperative  analgesia  and  morphine  usage.30
Moon  and  colleques  reported  that  using  esmolol  might
decrease  PACU  recovery  duration  in  gynecological  surgery
patients.6
In  this  study  we  observed  that  besides  lowering
anesthetic  requirements  adjuvant  esmolol  also  decreases
analgesic  requirements  and  VAS  scores  in  postoperative  24  h.
Some  previous  studies  also  supported  our  ﬁndings.  Bhawna
and  colleques  reported  that  in  lower  abdominal  surgery
patients  addition  of  esmolol  to  isoﬂurane  might  decrease
both  anestetic  and  postoperative  analgesic  requirements.31
Öztürk  and  colleques  reported  that  both  PNV  incidence  and
analgesic  requirements  decrease  in  laparoscopic  cholecys-
tectomy  patients  by  adjuvant  esmolol.  Two  similar  studies
also  reported  a  decrease  in  postoperative  pain  and  analgesic
requirements.8 Previous  studies  demonstrated  emotional
stress,  fear  and  anxiety  triggers  hippocampal  activation  in
magnetic  resonance  imaging.  These  changes  were  hought
to  be  secondary  to  a  neuroactive  substance  like  norepi-
nephrine.  Hippocampal  N-methyl-d-aspartate  (NMDA)  and
adrenergic  receptors  are  thought  to  play  role  in  percep-
tion.  Blockage  of  these  receptors  may  decrease  activation  of
adrenergic  activity  and  so  pain.32 Beta  blockers  might  also
decrease  hepatic  blood  ﬂow  and  metabolism  of  both  their
and  other  drugs  and  as  a  result  might  decrease  postoperative
analgesic  requirements.33,34
Another  ﬁnding  we  observed  in  our  study  was  decreased
PNV  and  antiemetic  requirements  in  patients  who  received
esmolol.  Hypertensive  patients  or  the  ones  who  develop
postoperative  hypotension  were  reported  to  have  increased
PNV  incidence  compared  to  other  populations.35 For  this  pur-
pose  hemodynamic  stability  during  and  just  after  surgery
is  important  to  prevent  PNV.36 From  this  perspective  we
found  that  patients  who  received  esmolol  did  not  have  any
blood  pressure  abnormality  (hypo  or  hypertension)  and  also
required  lower  doses  of  opioid  agents,  which  are  well  known
nausea  and  vomitting  triggering  agents.  We  think  that  these
might  be  the  cause  of  decreased  PNV  rates  in  these  patients.
However  there  is  conﬂicting  ﬁndings  in  literature  that  evalu-
ated  the  relationship  between  esmolol  and  PNV.  Öztürk  and
colleques  and  Coloma  and  colleques  reported  similar  ﬁnd-
ings  with  our  study.5,8 On  the  other  hand  Smith  and  colleques
did  not  observe  any  superiority  of  esmolol  in  means  of  PNV.1
Main  purpose  of  this  study  was  observing  and  comparing
effects  of  adding  esmolol  to  standart  anesthetic  protocols.
On  the  other  hand  we  also  had  opportunity  to  compare
propofol-remifentanil  based  and  desﬂurane-remifentanil
based  anesthesia  protocols.  According  to  our  ﬁndings  VAS
score  measured  in  PACU,  12th  and  24th  postoperative  hours
were  signiﬁcantly  lowest  in  group  I  (propofol-remifentanil
after  esmolol).  PNV  incidence  in  postoperative  24  h  was  also
signiﬁcantly  lowest  in  group  I  compared  to  all  other  groups.
Similarly  analgesic  requirements  in  postoperative  24  h  were
signiﬁcantly  lower  in  these  patients  compared  to  all  other
groups.  Depending  on  these  ﬁndings  we  think  that  propofol
based  anesthesia  protocols  might  be  advantageous  com-
pared  to  desﬂurane  based  protocols.  Supporting  our  ﬁndings
Song  et  al.  reported  that  propofol  was  signiﬁcantly  more
effective  compared  to  desﬂurane  in  means  of  preventing
PNV.37 However  in  means  of  pain  prevention  there  are  some
data  in  literature  that  contradicts  our  ﬁndings.  Hepag˘us¸lar
et  al.,  Fassoulaki  et  al.,  Ortiz  et  al.  reported  that  there  is
1usea,  vomitting  145
o  signiﬁcant  difference  between  propofol  and  sevoﬂurane
r  desﬂurane  based  anesthetic  protocols  in  means  of  post
perative  pain  prevention  in  3  different  studies.38--40 This
eld  needs  more  studies  for  clariﬁcation.
As  a  conclusion  we  observed  that  using  adjuvant
smolol  during  anesthetic  maintenance  of  laparoscopic
holecystectomy  patients  decreases  anesthetic--analgesic
equirements,  postoperative  pain  and  PNV  without  caus-
ng  any  hemodynamic  instability.  We  also  observed  that
ropofol-remifentanil  based  anesthesia  protocols  might  be
dvantageous  in  means  of  PNV  and  pain  prevention  com-
ared  to  desﬂurane-remifentanil  based  protocols.
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